Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. - Wikidata - wikimedia - TriplyDB

Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia.

Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia.

http://www.wikidata.org/entity/Q35779246

about

Regulation of TAZ in cancer Cancer stem cell metabolism Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction Cancer stem cell targeted therapy: progress amid controversies.Cancer research in need of a scientific revolution: Using 'paradigm shift' as a method of investigation Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity Autophagy in stem cells.Tumor cell vasculogenic mimicry: from controversy to therapeutic promise Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roads Metastatic cancer stem cells: from the concept to therapeutics Compensatory angiogenesis and tumor refractoriness Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma Can nanomedicines kill cancer stem cells?The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia The billion cell construct: will three-dimensional printing get us there?Cellular Plasticity in Prostate Cancer Bone Metastasis Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line Metabolic tumor profiling with pH, oxygen, and glucose chemosensors on a quantum dot scaffold.Wnt-responsive cancer stem cells are located close to distorted blood vessels and not in hypoxic regions in a p53-null mouse model of human breast cancer.Outcomes and prognoses of patients with ovarian cancer using bevacizumab: 6-year experience in a tertiary care hospital of northern Taiwan.Cancer stem cells: a systems biology view of their role in prognosis and therapy Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors.Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells.CoCl2, a mimic of hypoxia, induces formation of polyploid giant cells with stem characteristics in colon cancer.Targeting Head and Neck Cancer Stem Cells: Current Advances and Future Challenges Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer Biomarkers to Target Heterogeneous Breast Cancer Stem Cells VEGFR3 inhibition chemosensitizes ovarian cancer stemlike cells through down-regulation of BRCA1 and BRCA2.Antiangiogenic therapy using sunitinib combined with rapamycin retards tumor growth but promotes metastasis.Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule.XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.Pattern response of dendritic cells in the tumor microenvironment and breast cancer Metabolic differences in breast cancer stem cells and differentiated progeny.Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer Targeting unique metabolic properties of breast tumor initiating cells

P2860

Q26740462-A4D4A2CC-D649-407F-BB81-EA73D1E98090 Q26746123-A01D8BDF-8846-4A0B-9AA3-CA478902379D Q26749333-8829925A-1D07-4200-A195-C01B664C6C6B Q26779931-99A90EC1-A239-46DF-A040-447342CCEB57 Q26786406-128FB733-95B7-4FC5-948C-77E78ECDB9E5 Q26796292-018C20C9-CF84-48D4-BC2B-99B4617E2585 Q26823995-F42A92E3-DA78-4EC4-ABF8-50A4862849CE Q26829921-65B73459-2266-4F16-B14D-4C44B0E2D6AA Q26830075-6D299428-FBC0-4B1F-AA9D-00D68F4F097A Q26850739-8C8FCAE7-3051-400F-8CBA-EA08224DE5C7 Q26851916-0BBFA8E7-E415-4EC8-BD29-62F7D11FAA2C Q26866144-02CBC7AA-A67E-4F2A-A3C3-4468A1777696 Q26991991-09F82E47-516D-4201-8E4A-162CB4F7D4D2 Q27021470-54665C08-89ED-4C95-854B-1050398CE71E Q27022017-AF9B859A-F663-477C-B5C1-FA751227A876 Q27025579-6C0BF02F-660E-4CF3-9B64-94A715B9C68A Q27300346-3F552BD7-B413-4C9D-B15B-84CA4657C49A Q27314781-6B89924A-95B6-4BAF-B575-C3774C9E0E07 Q28085013-DE9BB8BC-4D2C-4C22-B1E9-5E149DC372AE Q28393898-7A653688-E095-4CFB-BE68-0458BCA584F9 Q28484299-A0A442DF-2641-4522-9584-42ACD1DCF819 Q28534236-A377FC00-F099-42F4-A642-9C4BF76552B7 Q30573562-B3728EFA-B31E-4DC4-851C-F4E2AFCEA2BC Q30581875-42A99087-2F2C-4324-BB9C-DF8E9D29FD12 Q33441574-0BFA8CF2-BF46-4D84-B8B4-C5DB27607D14 Q33569712-64BCF181-54CE-4FE2-8E39-E4E31E8A9FFA Q33598505-34CC4B85-334F-4898-BB78-33B593F08651 Q33726477-F9AB1E3B-22AB-4283-B339-943C9CEFE6AF Q33763237-8A99DEAF-ECF3-49E3-A5A7-E4CE48C21777 Q33793000-C41FADF4-57DC-4D9D-BC0E-6E3A14F7B6EA Q33798788-285D97CB-1DC7-49CE-AD80-3B839EB06E6F Q33811149-C40495F5-C262-400D-BB48-DFC316BCCEBD Q33891251-6264101C-D739-43ED-95CD-F87299D84640 Q33912305-FEFC1AB9-A7E0-4BBC-AE02-A436764CAA4B Q33913901-5B2CA12F-0F44-45A7-A768-6E0D595BF192 Q33926690-81F1B2E6-6032-4D18-A58B-9CA3A3850D98 Q34023724-9158556C-85BC-40E7-8B35-FA16D7F877D9 Q34039960-1C765FA6-12FD-435B-A222-CA5C09886B64 Q34080323-C1FB80ED-AD83-4AA6-92BD-CFA387DF4459 Q34089425-8B6FF4C3-C960-41FE-B72C-973B807CDFEF

P2860

Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia.

http://www.wikidata.org/entity/Q35779246

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Antiangiogenic agents increase ...... e generation of tumor hypoxia.

@ast

Antiangiogenic agents increase ...... e generation of tumor hypoxia.

@en

type

label

Antiangiogenic agents increase ...... e generation of tumor hypoxia.

@ast

Antiangiogenic agents increase ...... e generation of tumor hypoxia.

@en

prefLabel

Antiangiogenic agents increase ...... e generation of tumor hypoxia.

@ast

Antiangiogenic agents increase ...... e generation of tumor hypoxia.

@en

P1433

Q35779246-AEB6F0F0-213E-47E3-85A3-4B6411179FB6

P1476

Q35779246-FCA78E7A-32E0-4D5B-9E43-C3B178A00CED

P2093

Q35779246-040E5551-DE6B-4DE0-851F-ED57712F1C66

Q35779246-067E2D5C-2C1D-4096-A79D-4C267F09334B

Q35779246-12D5FEBA-48B1-46EA-A83D-51B8471DE320

Q35779246-64A444C2-BCAD-4722-959A-07EF96F20C67

Q35779246-82247673-F63E-4E33-9AA3-FB42CE56E252

Q35779246-94695BC7-6CDA-4645-9C25-5F56E7115EFD

Q35779246-A5AD5DB0-C2A7-4910-9854-F400C1FB8AE4

Q35779246-CB19A27A-099F-41D7-B7AD-5E6467ABB97D

P2860

Q35779246-029430AC-9507-4F4E-BAB2-D00D55550777

Q35779246-04CE2F78-B7B9-487C-ACE2-FC0F927F3A97

Q35779246-0626F1F9-F888-4959-BA9A-12E2DDAE3AC2

Q35779246-1206D948-3C0C-42D6-96BB-D2B9AA5C3A77

Q35779246-164AABC6-596C-443F-98C8-B4914E51A7C7

Q35779246-172302FA-BB2E-49D7-A110-0746FC9F86EF

Q35779246-224C934F-A35A-4551-9384-C02B0E275C6E

Q35779246-391BBAF7-E377-486E-AC59-A14EF5FB92E4

Q35779246-3BB7C1C6-6697-4BE6-BE70-2574EA6FA05B

Q35779246-3D1BB1C8-9E17-475D-9DB5-7ECD75ACFDEA

P304

Q35779246-471E2509-9420-440E-B1F4-9EF458FF61EC

P31

Q35779246-0DFFEC10-7CFA-45AD-8BED-039EF7C43CCB

P356

Q35779246-1FF38202-1223-45FE-866A-0A6F9D2D3F17

P407

Q35779246-C4A1BF30-427F-4B5A-8FD8-766F0B9B3F2C

P433

Q35779246-8D84C8A1-7E39-4DD5-B970-F753AAA98F8A

P478

Q35779246-B85DA8B0-2664-4C6C-B089-C4F94B48FC9B

P577

Q35779246-AD646B78-B139-403C-911A-5C360258F101

P5875

Q35779246-9D3773A1-2250-4C3E-9E17-F42A2F95A1CA

P698

Q35779246-CEFF32F0-9DC1-4FC2-891B-2F3D3255C4DE

P921

Q35779246-9F678D8D-9EDD-4E0B-B68E-77D2E57C8B61

P932

Q35779246-B4308DA7-AEE4-40DB-B8E3-FA0F24B1DCB6

P356

PNAS.1018866109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Antiangiogenic agents increase ...... e generation of tumor hypoxia.

@en

P2093

Amber N Heath

http://www.w3.org/2001/XMLSchema#string

Bryan Newman

http://www.w3.org/2001/XMLSchema#string

Elizabeth Gheordunescu

http://www.w3.org/2001/XMLSchema#string

Hasan Korkaya

http://www.w3.org/2001/XMLSchema#string

Max S Wicha

http://www.w3.org/2001/XMLSchema#string

Pramod Kakarala

http://www.w3.org/2001/XMLSchema#string

Sarah J Conley

http://www.w3.org/2001/XMLSchema#string

Shawn G Clouthier

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

The epithelial-mesenchymal transition generates cells with properties of stem cells

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Tumor angiogenesis: therapeutic implications

Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia

Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models

Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

Angiogenesis: an organizing principle for drug discovery?

P304

2784-2789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1018866109

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221808816

http://www.w3.org/2001/XMLSchema#string

P698

22308314

http://www.w3.org/2001/XMLSchema#string

P921

P932

3286974

http://www.w3.org/2001/XMLSchema#string